Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Did Sarepta Need To Tell Investors About Its Vyondys 53 Dispute Resolution Request?
Dec 16 2019
•
By
Brenda Sandburg
Sarepta did not publicly disclose that it made a formal dispute resolution request over Vyondys 53 complete response letter
More from Compliance
More from Pink Sheet